Baird Financial Group, Inc. Bio Techne Corp Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 754,327 shares of TECH stock, worth $55.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

754,327

Previous 653,141 15.49%

Holding current value

$55.2 Million

Previous $46.8 Million 28.81%

% of portfolio

0.12%

Previous 0.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$70.96 - $82.35 $7.18 Million - $8.33 Million	101,186 Added 15.49%	754,327 $60.3 Million
Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $2.38 Million - $3.23 Million	-38,387 Reduced 5.55%	653,141 $46.8 Million
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $2,177 - $2,543	-33 Reduced -0.0%	691,528 $48.7 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $28.7 Million - $42.5 Million	543,207 Added 366.16%	691,561 $53.4 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $3,646 - $4,828	-54 Reduced 0.04%	148,354 $10.1 Million
Q2 2023 Aug 11, 2023	BUY	$73.76 - $85.98 $811,064 - $945,436	10,996 Added 8.0%	148,408 $12.1 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $1.41 Million - $1.7 Million	-19,647 Reduced 12.51%	137,412 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $688,832 - $955,330	2,438 Added 7.0%	37,283 $10.6 Million
Q2 2022 Aug 08, 2022	BUY	$322.67 - $449.65 $235,871 - $328,694	731 Added 2.14%	34,845 $12.1 Million
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $425,327 - $586,323	-1,202 Reduced 3.4%	34,114 $14.8 Million
Q4 2021 Feb 09, 2022	BUY	$456.15 - $525.06 $1.51 Million - $1.73 Million	3,300 Added 10.31%	35,316 $18.3 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $2.25 Million - $2.73 Million	5,062 Added 18.78%	32,016 $15.5 Million
Q2 2021 Aug 11, 2021	BUY	$387.35 - $450.26 $106,908 - $124,271	276 Added 1.03%	26,954 $12.1 Million
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $151,332 - $197,691	-481 Reduced 1.77%	26,678 $10.2 Million
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $139,251 - $181,534	564 Added 2.12%	27,159 $8.62 Million
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $881,507 - $1.07 Million	3,796 Added 16.65%	26,595 $6.59 Million
Q2 2020 Oct 22, 2020	BUY	$185.43 - $279.56 $328,025 - $494,541	1,769 Added 8.41%	22,799 $6.02 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $249,959 - $376,846	-1,348 Reduced 6.02%	21,030 $4.62 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $101,859 - $139,994	632 Added 2.91%	22,378 $4.24 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $50,265 - $58,853	265 Added 1.23%	21,746 $4.77 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $71,771 - $84,737	391 Added 1.85%	21,481 $4.2 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $55,861 - $63,767	296 Added 1.42%	21,090 $4.4 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $2.33 Million - $3.43 Million	17,129 Added 467.37%	20,794 $4.13 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $40,621 - $62,362	-306 Reduced 7.71%	3,665 $530,000
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $15,628 - $21,635	-106 Reduced 2.6%	3,971 $809,000
Q2 2018 Aug 13, 2018	BUY	$144.9 - $165.58 $34,920 - $39,904	241 Added 6.28%	4,077 $603,000
Q1 2018 May 14, 2018	SELL	$131.46 - $151.04 $122,915 - $141,222	-935 Reduced 19.6%	3,836 $579,000
Q4 2017 Feb 09, 2018	SELL	$121.17 - $134.75 $169,638 - $188,650	-1,400 Reduced 22.69%	4,771 $618,000
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $103,253 - $112,516	909 Added 17.27%	6,171 $746,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,262	5,262 $618,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Bio Techne Corp Transaction History